Instituto Rosenbusch S.A. (BCBA:ROSE)
160.50
-1.00 (-0.62%)
At close: Jun 12, 2026
Instituto Rosenbusch Income Statement
Financials in millions ARS. Fiscal year is January - December.
Millions ARS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,404 | 10,886 | 9,860 | 4,276 | 1,523 | |
Revenue Growth (YoY) | -41.17% | 10.40% | 130.61% | 180.84% | 80.56% |
Cost of Revenue | 6,690 | 5,905 | 7,036 | 2,302 | 1,093 |
Gross Profit | -286.03 | 4,980 | 2,825 | 1,974 | 429.2 |
Selling, General & Admin | 2,449 | 2,428 | 2,517 | 1,054 | 397.23 |
Other Operating Expenses | 634.37 | 91.5 | 273.17 | 44.11 | -10.01 |
Operating Expenses | 3,083 | 2,520 | 2,790 | 1,098 | 387.22 |
Operating Income | -3,369 | 2,461 | 34.37 | 875.27 | 41.98 |
Interest Expense | -1,651 | -822.99 | -1,058 | -524.56 | -67.42 |
Interest & Investment Income | 0.23 | - | - | - | - |
Currency Exchange Gain (Loss) | 556.45 | -3,504 | 1,709 | -318.06 | -114.02 |
Other Non Operating Income (Expenses) | - | 0 | - | -0 | - |
EBT Excluding Unusual Items | -4,463 | -1,866 | 684.84 | 32.65 | -139.46 |
Gain (Loss) on Sale of Assets | - | - | 686.65 | - | - |
Other Unusual Items | - | - | - | - | 101.34 |
Pretax Income | -4,463 | -1,866 | 1,371 | 32.65 | -38.11 |
Income Tax Expense | 50.87 | 245.29 | 134.85 | 74.9 | 8.43 |
Earnings From Continuing Operations | -4,514 | -2,112 | 1,237 | -42.25 | -46.54 |
Minority Interest in Earnings | -83.74 | 247.16 | -10.76 | 17.04 | 8.42 |
Net Income | -4,598 | -1,864 | 1,226 | -25.22 | -38.12 |
Net Income to Common | -4,598 | -1,864 | 1,226 | -25.22 | -38.12 |
Shares Outstanding (Basic) | 43 | 43 | 43 | 43 | 43 |
Shares Outstanding (Diluted) | 43 | 43 | 43 | 43 | 43 |
EPS (Basic) | -107.95 | -43.78 | 28.78 | -0.59 | -0.90 |
EPS (Diluted) | -107.95 | -43.78 | 28.78 | -0.59 | -0.90 |
Free Cash Flow | 397.75 | 706.67 | 215.92 | 70.74 | 54.2 |
Free Cash Flow Per Share | 9.34 | 16.59 | 5.07 | 1.66 | 1.27 |
Gross Margin | -4.47% | 45.75% | 28.65% | 46.16% | 28.19% |
Operating Margin | -52.61% | 22.61% | 0.35% | 20.47% | 2.76% |
Profit Margin | -71.80% | -17.13% | 12.43% | -0.59% | -2.50% |
Free Cash Flow Margin | 6.21% | 6.49% | 2.19% | 1.65% | 3.56% |
EBITDA | -3,177 | 2,621 | 141.25 | 960.99 | 87.08 |
EBITDA Margin | -49.61% | 24.08% | 1.43% | 22.48% | 5.72% |
D&A For EBITDA | 192.08 | 160.55 | 106.89 | 85.72 | 45.1 |
EBIT | -3,369 | 2,461 | 34.37 | 875.27 | 41.98 |
EBIT Margin | -52.61% | 22.61% | 0.35% | 20.47% | 2.76% |
Effective Tax Rate | - | - | 9.83% | 229.42% | - |
Advertising Expenses | 10.51 | 16.7 | 21.43 | 9.55 | 4.34 |